Switch to:
More From Other Websites
Trials Of Agenus Inc (AGEN) Cancer Vaccine Ends In Absolute Failure Feb 23 2017
[2/23] This Week’s Earnings Revisions Movers Feb 23 2017
Lexington's Agenus quietly discloses failure of cancer vaccine trial Feb 22 2017
AGENUS INC Files SEC form 8-K, Regulation FD Disclosure Feb 21 2017
​Lexington-based Agenus reworks Incyte pact, freeing up $80M in cash Feb 14 2017
Incyte and Agenus Amend Drug Licensing Deal Feb 14 2017
AGENUS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of... Feb 14 2017
Incyte and Agenus Amend Collaboration Agreement Feb 14 2017
Agenus, Inc. – Value Analysis (NASDAQ:AGEN) : February 8, 2017 Feb 08 2017
Agenus, Inc. breached its 50 day moving average in a Bullish Manner : AGEN-US : February 7, 2017 Feb 07 2017
Agenus Appoints Jean-Marie Cuillerot, M.D. Chief Medical Officer Jan 30 2017
Agenus Inc (AGEN) Incorporates NCI In Evaluation Of Prophage-Keytruda Combo Jan 19 2017
Clinical Trial Hopes Drugs Help Body Fight Cancer Jan 18 2017
Agenus, NCI Ink Deal to Evaluate Prophage-Keytruda Combo Jan 18 2017
AGENUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 17 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK